(Q33983469)

30 July 2017

title

In vitro and in vivo activities of sitafloxacin against Chlamydia spp (English)

1 reference

30 July 2017

N Miyashita

1

1 reference

30 July 2017

Y Niki

series ordinal

2

1 reference

30 July 2017

T Matsushima

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

45

1 reference

30 July 2017

issue

11

1 reference

30 July 2017

page(s)

3270-3272

1 reference

Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

Chlamydia pneumoniae (TWAR).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

In vitro activities of five quinolones against Chlamydia pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

Etiology of community-acquired pneumonia requiring hospitalization in Japan

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90824

A simplified method of evaluating dose-effect experiments

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11600398

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Preliminary report on DU-6859a for lower respiratory tract infection.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11600398

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.45.11.3270-3272.2001

1 reference

30 July 2017

1 reference

30 July 2017

1 reference